Trump Postpones AI Executive Order Citing Concerns Over Potential Innovation Barriers China Urges APEC Cooperation Amid Commerce Ministers Absence Due to Urgent Official Business Recursion Pharmaceuticals Shares Slide to 52Week Low Amid Sector Headwinds Analyst Target Prices for Raymond James Stock What Investors Should Know Oil Prices Tumble Over 5 as Iran Nuclear Deal Prospects Weigh on Market Professional Title Gen Z Faces Diminishing Returns on Higher Education Amid Broader Economic Instability MLTX Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline Gladstone Land Corporation 600 Series C Cumulative Redeemable Preferred Stock LANDP Q1 2026 Earnings Narrower Loss Surprises as Preferred Coverage Held Steady IRIX Q1 2026 Earnings EPS Surprises to the Upside Despite Limited Revenue Disclosure Best Buy Co BBY Q1 2026 Earnings Solid EPS Beat Amid Mixed Consumer Electronics Demand CETY Q4 2024 Earnings Net Loss of 002 Per Share as Clean Energy Firm Navigates Growth Phase THRY Q1 2026 Earnings Significant EPS Beat Surprises Market Evergy EVRG Slips 157 as Utility Sector Faces Headwinds Key Levels in Focus Shopify SHOP Dips 177 as Price Tests Key Support Near 9785 Spartacus Acquisition Corp II Unit TMTSU Trading Flat Near NAV as Merger Search Continues BlackRock Health Sciences Term Trust BMEZ Holds Steady Near Support as Sector Momentum Builds Lulus Fashion Lounge LVLU Sees 39 Decline Evaluating Key Support and Resistance Levels Clorox CLX Gains Ground Consumer Staples Stock Rebounds Amid Defensive Demand Walmart WMT Edges Higher as Defensive Appeal Supports Modest Gains LaFayette Acquisition Corp Rights LAFAR Holds Steady at 012 Trading Range Narrows GAMCO Global Gold Natural Resources Income Trust GGN Weakness Testing Support Zone as Gold Sector Faces Headwinds Molina Healthcare Shows Modest Gains as Sector Tailwinds Support MOH PennyMac Financial Services PFSI Edges Higher Key Levels in Focus Global Firms Leverage AI at Indian Hubs to Shift Advertising Work InHouse CFR Q1 2026 Earnings Solid EPS Beat Amid Stable Performance Pliant Therapeutics PLRX Holds Near Support Amid Modest Gains Key Levels in Focus